CamGene Therapeutics

Developer of nanoparticle-based mRNA therapeutic drugs designed for patients who have lost their hearing. The company's lipid nanoparticle-based mRNA technology precisely targets ear cells to deliver ...

Healthcare
Cambridge, United Kingdom
Founded 2023
5 employees
Website
Valuation
$8.8M
Market implied
Share Price
N/A
Total Raised
$4.9M
Last Round
N/A

Get the full picture

Create a free account to unlock CamGene Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required